Trial site
Asklepios Fachkliniken Muenchen-Gauting
- 11running trials
- 10closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Lung cancer21 trials
- Mesothelioma1 trial
- Neuroendocrine tumours1 trial
- Phase
- Phase 317 trials
- Phase 23 trials
- Phase 1/21 trial
- Status
- Completed10 trials
- Active, not recruiting8 trials
- Recruiting3 trials
- Lead sponsor
- Amgen3 trials
- AstraZeneca2 trials
- Bristol-Myers Squibb2 trials
- AbbVie1 trial
- Abbvie Deutschland GmbH & Co. KG1 trial
- and 12 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Recruiting
Recruiting
Active, not recruiting
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Active, not recruiting
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Neuroendocrine tumours1 recruiting
Closed trials
Completed
A Phase 1/2 Study of DCC-3116 in Patients With MAPK Pathway Mutant Solid Tumors
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026